SARS-CoV-2 Alpha variant

SARS-CoV-2 Alpha variant

20B/501Y.V1, 20I/501Y.V1, 501.V1, 501.V1 variant, Alpha (SARS-CoV-2), Alpha variant, B.1.1.7, B.1.1.7 lineage, B.1.1.7 variant, B1.1.7, B117 coronavirus, B117 COVID, B117 COVID-19, B117 pandemic, B117 strain, B117 strain coronavirus, B117 strain COVID, B117 strain COVID-19, British virus, COVID-19 Alpha, COVID-19 UK strain, COVID-19 UK variant, Covid alpha, first Variant Under Investigation in December 2020, H69/V70, Kent COVID-19 variant, Kent variant, Kent variant COVID, Kent variant COVID-19, Kent virus variant, Lineage B.1.1.7, U.K. Coronavirus variant, U.K. Covid-19 variant, U.K. COVID19 variant, U.K. covid variant, U.K. strain, U.K. variant, UK coronavirus variant, UK Coronavirus variant, UK Covid-19 variant, UK COVID-19 variant, UK COVID19 variant, UK covid variant, UK strain, UK variant, Variant B.1.1.7, Variant B117, Variant of Concern 202012/01, Variant Under Investigation in December 2020, VOC-202012/01, VOC - 202012/01, VUI-202012/01, VUI - 202012/01, VUI – 202012/01

20I/S:501Y.V1, Alpha variant, B.1.1.7, B.1.1.7 lineage, B117, British variant, GR/501Y.V1, GRY, Lineage B.1.1.7, lineage B.1.1.7, N501Y mutation, UK coronavirus variant, UK COVID-19 variant, UK variant, Variant of Concern 202012/01, VOC-202012/01, VUI-202012/01, VUI – 202012/01